On August 19, Shenzhen Salubris Pharmaceuticals Co.,Ltd. released its half-year report.
According to the announcement, the company's half-year operating revenue reached 2,130,967,669.97 yuan, representing a year-over-year increase of 4.32%. Net profit attributable to shareholders of the listed company was 365,078,698.05 yuan, up 6.1% year-over-year.
The announcement also revealed that among the top ten circulating shareholders, Agricultural Bank of China Co.,Ltd. - CSI 500 Exchange Traded Fund has become a new circulating shareholder.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments